Judd Boczko, MD
Urology · White Plains, NYNPI 1740258169
Payments from drug & device makers
Across 52 payments — averaging $35.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- SRS Medical Systems, Inc.$750
- Acerus Pharmaceuticals Corporation$608
- Olympus America Inc.$141
- EDAP Technomed Inc$66
- Neotract Inc.$66
- Sumitomo Pharma America, Inc.$57
- plus $157 from 6 others
Across 1 payment — averaging $12,000 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- SRS Medical Systems, Inc.$12K
What the payments were for
- Consulting fees$75041%
- Food & beverage$1,09559%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| SRS Medical Systems, Inc. | 1 | $750 |
| Acerus Pharmaceuticals Corporation | 27 | $608 |
| Olympus America Inc. | 9 | $141 |
| EDAP Technomed Inc | 3 | $66 |
| Neotract Inc. | 2 | $66 |
| Sumitomo Pharma America, Inc. | 3 | $57 |
| Boston Scientific | 2 | $53 |
| Myovant Sciences Inc. | 1 | $26 |
| Urogen Pharma, Inc. | 1 | $22 |
| Hollister Incorporated | 1 | $21 |
| Coloplast | 1 | $19 |
| Teleflex LLC | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- UroCuff$750
How this compares
$1,845 in reported general payments places this provider in the 40th percentile of 952 urology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 121 | $104,323 |
| Tamsulosin Hcl | 1,682 | $22,502 |
| Finasteride | 966 | $13,518 |
| Silodosin | 113 | $12,479 |
| Trospium Chloride | 114 | $12,169 |
| Mirabegron ErMirabegron | 19 | $12,167 |
| Oxybutynin Chloride ErOxybutynin Chloride | 329 | $10,158 |
| Potassium Citrate ErPotassium Citrate | 82 | $8,832 |
| Solifenacin Succinate | 80 | $7,982 |
| Estradiol | 81 | $7,265 |
| Trospium Chloride ErTrospium Chloride | 13 | $4,443 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 78 | $2,522 |
| Dutasteride | 51 | $2,223 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 75 | $972 |
| Cefdinir | 115 | $896 |
Paid to pharmacies, not to this prescriber.
Other urology in White Plains
- Christopher PieczonkaSyracuse$31.2M
- Guarionex DecastroNew York$5.7M
- Mitchell EfrosGarden City$4.2M
- James McKiernanNew York$4.1M
- William HuangNew York$3.9M
- Jed KaminetskyMiddle Village$3.5M
- Evan GoldfischerPoughkeepsie$3.1M
- Gennady BratslavskySyracuse$2.5M
- Ashutosh TewariNew York$2.5M
- Manish ViraNew Hyde Park$2.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.